Q3 EPS Estimates for Moelis & Company Cut by Zacks Research

Moelis & Company (NYSE:MC - Free Report) - Research analysts at Zacks Research lowered their Q3 2025 earnings estimates for Moelis & Company in a research report issued to clients and investors on Wednesday, January 29th. Zacks Research analyst R. Department now anticipates that the asset manager will post earnings per share of $0.60 for the quarter, down from their prior forecast of $0.61. The consensus estimate for Moelis & Company's current full-year earnings is $1.05 per share. Zacks Research also issued estimates for Moelis & Company's Q4 2025 earnings at $0.86 EPS and FY2025 earnings at $2.39 EPS.

Other research analysts also recently issued reports about the company. Keefe, Bruyette & Woods raised Moelis & Company from a "market perform" rating to an "outperform" rating and lifted their target price for the stock from $71.00 to $86.00 in a report on Friday, December 20th. UBS Group lifted their price objective on Moelis & Company from $54.00 to $60.00 and gave the stock a "sell" rating in a research note on Tuesday, October 8th. Wells Fargo & Company decreased their target price on shares of Moelis & Company from $78.00 to $77.00 and set an "equal weight" rating for the company in a research report on Tuesday, January 14th. Finally, Morgan Stanley upgraded shares of Moelis & Company from an "underweight" rating to an "overweight" rating and boosted their price target for the stock from $66.00 to $92.00 in a research report on Monday, December 9th. One analyst has rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $70.67.

Moelis & Company Stock Up 0.2 %

Shares of MC stock traded up $0.12 during trading hours on Friday, hitting $77.70. 701,213 shares of the company's stock traded hands, compared to its average volume of 662,806. Moelis & Company has a 12 month low of $46.24 and a 12 month high of $81.60. The stock has a market cap of $5.82 billion, a PE ratio of 146.61 and a beta of 1.40. The stock's 50 day simple moving average is $75.30 and its 200 day simple moving average is $70.51.

Institutional Investors Weigh In On Moelis & Company

A number of large investors have recently bought and sold shares of the stock. Bank of Montreal Can grew its stake in Moelis & Company by 2.7% in the second quarter. Bank of Montreal Can now owns 7,181 shares of the asset manager's stock valued at $409,000 after acquiring an additional 192 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in shares of Moelis & Company by 12.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 54,462 shares of the asset manager's stock worth $3,097,000 after purchasing an additional 5,954 shares in the last quarter. Algert Global LLC bought a new stake in Moelis & Company during the 2nd quarter valued at $382,000. Sanctuary Advisors LLC bought a new stake in Moelis & Company during the 2nd quarter valued at $554,000. Finally, GAMMA Investing LLC raised its holdings in Moelis & Company by 115.8% during the third quarter. GAMMA Investing LLC now owns 995 shares of the asset manager's stock worth $68,000 after buying an additional 534 shares during the last quarter. 91.53% of the stock is currently owned by institutional investors and hedge funds.

About Moelis & Company

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.